ASCO® 2023 Insights: "KEYNOTE-671 Trial Key Learnings & Clinical Implications - Pembro + Chemo Followed by Resection and Adjuvant Pembro for Early NSCLC"
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Jack West
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Jack West
Login to view comments.
Click here to Login